Clinical Trials Browser

Phase NA × Prostatic Neoplasms × ruxolitinib × Clear all

NCT03274778 2025-11-18

Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells

Phase NA Withdrawn

Prostatic Neoplasms